Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 404 followers
Latest posts
Last updated 1 day ago
Accelerating clinical trials with precision logistics
1 day ago
Learn how Marken’s Laboratory Advantage improves speed, visibility and compliance to keep...
FDA snubs AbbVie's prospective Botox heir amid series of manufacturing-related CRLs
2 days ago
The FDA rejected two new products from AbbVie and Grace Therapeutics, citing...
Sanofi gains long-awaited win for tolebrutinib as EU regulator endorses MS drug for approval
2 days ago
After a series of setbacks for Sanofi’s tolebrutinib, the French company has...
Daiichi pushes back annual report, citing reviews amid ‘rapidly changing business conditions’
2 days ago
Daiichi Sankyo has postponed its annual report by two weeks, citing additional...
Travere’s launchpad positions Filspari for fast rise toward blockbuster sales: analyst
2 days ago
An established sales force and payer authorization criteria will fuel a fast...
Genentech wants ‘All Eyes on DME’ as it taps Damon Wayans for humor-laced campaign
2 days ago
Roche’s Genentech unit is launching a new multimedia campaign aimed at sharing...
Can Trump’s deal with the UK become a model for similar drug price agreements?
2 days ago
Trump’s deal with the UK links tariffs to drug pricing. On this...
Pfizer's cost-cutting push reaches Ireland again as it plans manufacturing layoffs
2 days ago
During Pfizer's right-sizing push after the COVID-19 pandemic, the company's multibillion-dollar cost-cutting...
Pfizer drafts Fernando Mendoza as new face of its ‘game of inches’ cancer campaign
2 days ago
Pfizer is kicking off the next stage of its cancer awareness program...
Fierce Pharma Asia—Merck’s PD-1xVEGF data; Zai Lab’s global view; Kailera’s record IPO
2 days ago
Merck & Co. unveiled the much-anticipated first look at its PD-1xVEGF bispecific...
Avalyn aims for $182M IPO to fund phase 3 trials of reformulated respiratory drugs
2 days ago
Avalyn Pharma is hoping to rake in around $181.8 million from an...
Patients less confident than ever about health choices: survey
2 days ago
Patients’ confidence in their ability to find answers about health questions and...